ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Pancreas Transplants Outcomes in Diabetes Mellitus Type 1 and Type 2 in the 21st Century: Are They Two Different Populations?

M. Merzkani1, H. Murad2, M. Wang1, V. Hu1, M. Ji3, Y. Al-Hosni1, O. Alzahabi1, M. Zayed1, J. Wellen4, K. Lentine5, S. Chang6, T. Alhamad7

1Washington University, St Louis, MO, 2Washington University in St Louis, Chesterfield, MO, 3Washington University in St. Louis School of Medicine, Saint Louis, MO, 4Washington University School of Medicine, Saint Louis, MO, 5SLU, St Louis, MO, 6Surgery, Washington University School of Medicine, Saint Louis, MO, 7Washington University School of Medicine at St. Louis, Saint Louis, MO

Meeting: 2022 American Transplant Congress

Abstract number: 1151

Keywords: Prognosis

Topic: Clinical Science » Pancreas » 65 - Pancreas and Islet: All Topics

Session Information

Session Name: Pancreas and Islet: All Topics

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Pancreas alone transplant (PT) has been associated with decreased progression and regression of microvascular and macrovascular complications. In this current era of standardized immunosuppression, there have been few studies in PT comparing the type of diabetes mellitus type 1 (DMT1) and 2 (DMT2) with their outcomes. In this study, we explore the association between the DMT1 versus DMT2 and transplant outcomes in PT patients.

*Methods: We reviewed Organ Procurement and Transplantation Network (OPTN) data on pancreas alone transplants between 1/1/2000 and 6/12/2020 in patients aged ≥18 years. Exclusion criteria were simultaneous transplant, PT after kidney transplant, PT that was not due to DMT1 or DMT2, pancreas from donors after cardiac death. The outcomes were death censored graft loss (DCGL) and death. The association of each outcome was analyzed using multivariable Cox regression including adjustment for recipient, donor, and transplant characteristics (Table1 and 2).

*Results: After exclusion criteria, 1155 PTs were analyzed. Patients with DMT2 were not at higher risk for DCGL compared with those with DMT1 (multivariable-adjusted hazard ratio, aHR=0.91, 95% confidence interval, CI [0.55-1.50]). DMT2 was associated with increased risk for death aHR =4.14, 95% CI [2.81-6.11] compared with DMT1. Other risk factors associated with higher risk for DCGL were Hispanics recipients and other race for recipients, Donor Race of American Indian/Alaskan and length diabetes less than 24 months (Table1). Other risk factors associated with increased risk for death were recipients >50 years, recipients with a BMI<18.5, Hispanic recipients, and length of diabetes mellitus <24 months (Table2).

*Conclusions: In PT patients, there was no difference in DCGL between DMT2 and DMT1, but DMT2 was associated with increased risk for death, compared to DMT1. There were several morbidities that we could not adjust for such coronary artery disease, stroke, and recurrent infections. More granular data and studies with a longer follow-up are needed to determine the cause and characteristics of DMT2 in PT patients to explain the increased risk for death compared with DMT1.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Merzkani M, Murad H, Wang M, Hu V, Ji M, Al-Hosni Y, Alzahabi O, Zayed M, Wellen J, Lentine K, Chang S, Alhamad T. Pancreas Transplants Outcomes in Diabetes Mellitus Type 1 and Type 2 in the 21st Century: Are They Two Different Populations? [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/pancreas-transplants-outcomes-in-diabetes-mellitus-type-1-and-type-2-in-the-21st-century-are-they-two-different-populations/. Accessed May 11, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences